PhRMA’s Lori Reilly joined CSG to discuss the industry’s response to COVID-19 and what it means for states
By Sarah Sutton | July 13, 2020
Recently, Lori Reilly, Chief Operating Officer at PhRMA, participated in a podcast with the Counsel of State Governments (CSG) to discuss the important work the biopharmaceutical industry is doing...
Read More
R&D Focus: 5 things to know about the biopharmaceutical research ecosystem
By Jocelyn Ulrich | July 13, 2020
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. In recent...
Read More
The latest: What they are saying: Importance of intellectual property protections to combat COVID-19
By Tom Wilbur | July 2, 2020
America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective
By Richard Moscicki, M.D. | June 29, 2020
As the world continues to feel the impact of COVID-19, the biopharmaceutical industry is working around the clock to identify and develop safe and effective vaccines to prevent infection, while...
Read More
In combating COVID-19, science is how we get back to normal
By Lori Reilly | June 24, 2020
America’s biopharmaceutical companies are working around the clock to combat a common enemy: COVID-19. As the fight to research and develop innovative treatments and vaccines advances, I’m pleased...
Read More
Guest Post: From lab to jab: Vaccine development to prevent COVID-19
By Guest Contributor | June 11, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
What scientific experts are saying about vaccine safety
By Andrew Powaleny | June 4, 2020
Vaccines have played a critical role in reducing the spread of, and in some cases, eliminating the threat of many devastating infectious diseases. They are often cited as second only to clean...
Read More
Guest Post: What will we learn from COVID-19?
By Guest Contributor | May 27, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Clinical Trials Awareness Week: Recognizing unsung heroes in medical research
By Richard Moscicki, M.D. | May 18, 2020
This week is Clinical Trials Awareness Week — an event to recognize the importance of clinical trials, raise public awareness of clinical research and honor clinical research professionals and...
Read More
Guest Post: Preserving clinical research sites during the coronavirus pandemic
By Guest Contributor | April 29, 2020
Conversations and healthy debate about issues facing our industry and the healthcare system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
